Azienda Sanitaria Regionale del Molise (ASREM)

The medical center is at the forefront of oncology research, particularly in the treatment of breast cancer. This area of study focuses on the optimal integration of chemotherapy and aromatase inhibitors for post-menopausal patients with endocrine-responsive early breast cancer.

• Concurrent vs. Sequential Therapy
• Adjuvant Treatment Strategies
• Endocrine-Responsive Tumors

By exploring the timing and combination of these therapies, the center aims to enhance the prevention of disease recurrence, offering new hope for patients worldwide.

In the realm of cardiovascular research, the center is pioneering studies on the impact of colchicine and aspirin in patients with type 2 diabetes. This research is crucial for improving cardiovascular outcomes in high-risk patients who have not yet experienced cardiovascular events.

• Cardiovascular Risk Reduction
• Combination Therapy Efficacy
• Preventive Strategies in Diabetes

The center's work in this field is instrumental in developing preventive strategies that could significantly reduce the incidence of cardiovascular complications in diabetic patients.